Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neurocrine Biosciences

126.55
-0.7600-0.60%
Post-market: 126.550.00000.00%17:01 EDT
Volume:1.58M
Turnover:199.40M
Market Cap:12.52B
PE:42.79
High:128.38
Open:127.88
Low:125.53
Close:127.31
Loading ...

Analysts Offer Insights on Healthcare Companies: Milestone Scientific (MLSS), Neurocrine (NBIX) and Argenx Se (ARGX)

TIPRANKS
·
23 Apr

Neurocrine Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
22 Apr

With EPS Growth And More, Neurocrine Biosciences (NASDAQ:NBIX) Makes An Interesting Case

Simply Wall St.
·
22 Apr

Neurocrine price target lowered to $168 from $185 at H.C. Wainwright

TIPRANKS
·
22 Apr

Neurocrine Biosciences, Inc. : H.c. Wainwright Cuts Target Price to $168 From $185

THOMSON REUTERS
·
22 Apr

Bank of America Securities Sticks to Its Buy Rating for Neurocrine (NBIX)

TIPRANKS
·
17 Apr

Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2025 Financial Results

PR Newswire
·
15 Apr

Neurocrine Biosciences Faces Relatively Less Exposure to FDA and Tariff-Related Concerns, RBC Says

MT Newswires Live
·
15 Apr

Neurocrine Raised to Outperform From Sector Perform by RBC Capital

Dow Jones
·
14 Apr

BUZZ-RBC upgrades Neurocrine Biosciences on low tariff exposure for key drug

Reuters
·
14 Apr

RBC Upgrades Neurocrine Biosciences to Outperform From Sector Perform, Trims Price Target to $137 From $138

MT Newswires Live
·
14 Apr

Neurocrine Biosciences Inc : RBC Raises to Outperform From Sector Perform; Cuts Target Price to $137 From $138

THOMSON REUTERS
·
14 Apr

Implied Volatility Surging for Neurocrine Biosciences (NBIX) Stock Options

Zacks
·
07 Apr

Neurocrine Biosciences Appoints New Chief Medical Officer

MT Newswires Live
·
05 Apr

Neurocrine Is Maintained at Buy by UBS

Dow Jones
·
04 Apr

Neurocrine Biosciences Appoints Dr. Keswani as CMO

TIPRANKS
·
04 Apr

Neurocrine names Dr. Sanjay Keswani as Chief Medical Officer

TIPRANKS
·
04 Apr

BRIEF-Neurocrine Biosciences Appoints Dr. Sanjay Keswani As Chief Medical Officer

Reuters
·
04 Apr

Neurocrine Biosciences Appoints DR. Sanjay Keswani as Chief Medical Officer

THOMSON REUTERS
·
04 Apr

Press Release: Neurocrine Biosciences Appoints Dr. Sanjay Keswani as Chief Medical Officer

Dow Jones
·
04 Apr